Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by KarlGibbonson Aug 14, 2024 10:20pm
450 Views
Post# 36179817

Tight Liquidity

Tight LiquidityAs it turns out, the company was not able to grow off of the Q2 numbers and it appears that QIPT is a flat (at best) to declining business.  You can be sure mgmt pulled out all the stops to not show a decline from Q2.  Some observations:

Cash is down to $14.4 million.  This is a bit worrying as they also stretched accounts payable to over $32 million, up from $24-25 million at the end of last year...this means, they have to pay down $6-7 million of cash payables to normalize.  Of course, A/R is also hight but they are starting to take higher provisions which calls into question whether they can recover them.  They also drawed on the revolver again this Q after doing so last Q...real cash adjusted for these things might be well betlow $10 million...and that's before any DOJ settlement.

All those acquisitions ($150 million spent) and the associated high cost debt and they have a flat to declining businesses that looks cash flow negative.  Very, very poor capital allocators.


<< Previous
Bullboard Posts
Next >>